BusyMed aims to connect consumers directly to pharmacies via a digital platform, giving them access to online consultations, product and medication purchases with fast home delivery. It was founded on the belief that quality healthcare should be and can be accessible to everyone.
The platform allows for pharmacies to provide real-time stock information, access performance data on best-selling items, manage inventory more effectively and leverage off existing pharmacy and 3rd party delivery solutions.
Furthermore, it facilitates and closes a gap where the end consumer may need to secure doctors’ consultations and provides an online prescription management service.
“We’re excited about the opportunity this investment provides us. BusyMed aims at improving pharmacies’ engagement with their communities through technology and by doing so brings access to quality healthcare into everyone’s home,” Mphati Jezile, BusyMed founder said.
Customers are looking for convenience and less physical interaction now more than ever, and with growing competition in the retail pharmacy industry, BusyMed enables these businesses to better compete and at the same time better serve their communities.
“The Agility Fund is an impact investment fund that invests in ventures that have a social benefit whilst providing a potentially high yielding investment for our investors,” Deven Govender, LionPride CEO, said.
“It’s great that we can support a young and talented entrepreneur like Mphati in a venture that utilises technology to enable access to healthcare for communtiies across the country. Not only do we see human potential in Mphati and the impact of Busymed in South Africa’s communities, but as a fund manager the investment has to make sense as well, and we believe it does.”
“In Mphati you have an entrepreneur who is committed to making a difference in the healthcare sector by adopting technology platforms, and we cannot wait to see BusyMed develop and grow, and are thankful to have been a small part of their exciting journey.”